These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14686306)

  • 1. Testing gains shown in antiretroviral resistance. Research addresses new recommendations.
    AIDS Alert; 2003 Sep; 18(9):114-7. PubMed ID: 14686306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV resistance testing. A clinical tool.
    Paul SM; Jorden VS
    N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV resistance testing: a new clinical tool.
    Jorden VS; Paul SM
    N J Med; 2000 Oct; 97(10):33-8. PubMed ID: 11064565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
    Hicks CB
    AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
    [No Abstract]   [Full Text] [Related]  

  • 5. Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.
    Hirsch MS; Brun-Vézinet F; Clotet B; Conway B; Kuritzkes DR; D'Aquila RT; Demeter LM; Hammer SM; Johnson VA; Loveday C; Mellors JW; Richman DD;
    Top HIV Med; 2003; 11(4):150-4. PubMed ID: 12876334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
    Zolopa AR
    J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated European recommendations for the clinical use of HIV drug resistance testing.
    Vandamme AM; Sönnerborg A; Ait-Khaled M; Albert J; Asjo B; Bacheler L; Banhegyi D; Boucher C; Brun-Vézinet F; Camacho R; Clevenbergh P; Clumeck N; Dedes N; De Luca A; Doerr HW; Faudon JL; Gatti G; Gerstoft J; Hall WW; Hatzakis A; Hellmann N; Horban A; Lundgren JD; Kempf D; Miller M; Miller V; Myers TW; Nielsen C; Opravil M; Palmisano L; Perno CF; Phillips A; Pillay D; Pumarola T; Ruiz L; Salminen M; Schapiro J; Schmidt B; Schmit JC; Schuurman R; Shulse E; Soriano V; Staszewski S; Vella S; Youle M; Ziermann R; Perrin L
    Antivir Ther; 2004 Dec; 9(6):829-48. PubMed ID: 15651743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
    Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
    Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic resistance tests in the management of the HIV-infected patient at virological failure.
    Aceti A; Carosi G
    Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
    Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
    Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV drug resistance testing: an update for the clinician.
    Rice HL; Zolopa AR
    AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral drug resistance and resistance testing.
    Gallant JE
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOHMH recommendations for treating at-risk patients.
    AIDS Alert; 2005 Apr; 20(4):39. PubMed ID: 15841525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of resistance to antiretroviral therapy in the minority community.
    Rodriguez AE; Campo RE; Gathe JC; Kwakwa HA
    AIDS Read; 2004 Oct; 14(10 Suppl):S9-11. PubMed ID: 15497217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It's the best time to get HIV, and the worst. While the virus finds its way around the drugs, newer treatments hold hope.
    Fallon SJ
    Posit Aware; 2005; 16(3):32-4. PubMed ID: 16477708
    [No Abstract]   [Full Text] [Related]  

  • 20. Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.
    Dianzani F; Frascione E
    Scand J Infect Dis Suppl; 2003; 106():108-9. PubMed ID: 15000599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.